Skip Navigation


European Heart Journal Advance Access originally published online on June 13, 2008
European Heart Journal 2008 29(16):2058-2059; doi:10.1093/eurheartj/ehn263
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/16/2058-a    most recent
ehn263v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mellbin, L. G.
Right arrow Articles by Wedel, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mellbin, L. G.
Right arrow Articles by Wedel, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Cardiovascular prevention in high-risk patients with type 2 diabetes mellitus: when to start it?: reply

Linda G. Mellbin

Department of Cardiology
Karolinska University Hospital Solna
171 76 Stockholm
Sweden
Tel: +46 8 51 77 21 71
Fax: +46 8 34 49 64
Email: linda.mellbin@karolinska.se

Lars Rydén

Department of Cardiology
Karolinska University Hospital Solna
171 76 Stockholm
Sweden

Klas Malmberg

Department of Cardiology
Karolinska University Hospital Solna
171 76 Stockholm
Sweden

Anna Norhammar

Department of Cardiology
Karolinska University Hospital Solna
171 76 Stockholm
Sweden

Hans Wedel

Nordic School of Public Health
Göteborg
Sweden

The first 10% of the full text of this article appears below.

We are grateful for the attention our article on the potential drawback of insulin in patients has attracted, most recently in the letter to the Editor by Drs Garcia and Lopez-Jaramillo. This debate may encourage further efforts to study the proper use of this and other glucose-lowering drugs and serves as an incitement to . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?